Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage

被引:36
作者
Iseda, Keiichi [1 ]
Ono, Shigeki [1 ]
Onoda, Keisuke [1 ]
Saroh, Motoyoshi [1 ]
Manabe, Hiroaki [1 ]
Nishiguchi, Mitsuhisa [1 ]
Takahashi, Kenji [1 ]
Tokunaga, Koji [1 ]
Sugiu, Kenji [1 ]
Date, Isao [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama 7008558, Japan
关键词
caspase inhibitor; cerebral vasospasm; inflammation; macrophage; subarachnoid hemorrhage;
D O I
10.3171/JNS-07/07/0128
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Inflammation in the subarachnoid space and apoptosis of arterial endothelial cells have been implicated in the development of delayed cerebral vasospasm after subarachnoid hemorrhage (SAH). The authors investigated mechanisms of possible antivasospastic effects of N-benzyl-oxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-FMK), a caspase inhibitor that can inhibit both inflammatory and apoptotic systems., in animal models of SAH. Methods. Rabbits were assigned to three groups of eight animals each and were subjected to SAH by injection of blood into the cisterna magna. The experiments were performed in the following groups: SAH only, SAH + vehicle, and SAH + Z-VAD-FMK. The Z-VAD-FMK (1 mg) or vehicle (5% dimethyl sulfoxide) was intrathecally administered before SAH induction. Diameters of the basilar artery (BA) were measured on angiograms obtained before and 2 days after SAH. The BA diameter on Day 2 was expressed as a percentage of that before SAH. Interleukin (IL)-1 beta in the cerebrospinal fluid (CSF) was examined using Western blotting, and brains were immunohistochemically examined for caspase-1 and IL-1 beta. In a separate experiment, 20 rats were subjected to SAH and their brains were immunohistochemically assessed for caspase-1, IL-1 beta, and macrophages. Results. In rabbits, Z-VAD-FMK significantly attenuated cerebral vasospasm (the BA diameter on Day 2 in SAH-only, SAH + vehicle, and SAH + Z-VAD-FMK groups was 66.6 +/- 3.2%, 66.3 +/- 3.7%, and 82.6 +/- 4.9% of baseline, respectively), and suppressed IL-1 beta release into the CSF and also suppressed immunoreactivities of caspase- I and IL-1 beta in macrophages infiltrating into the subarachnoid space. Immunoreactivities for caspase- I and IL-1 beta were observed in immunohistochemically proven infiltrating macrophages in rats. Conclusions. These results indicate that caspase activation may be involved in the development of SAH-induced vasospasm through inflammatory reaction.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 36 条
[1]   Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits [J].
Bavbek, M ;
Polin, R ;
Kwan, AL ;
Arthur, AS ;
Kassell, NF ;
Lee, KS .
STROKE, 1998, 29 (09) :1930-1935
[2]   Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways [J].
Beasley, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (03) :323-330
[3]   Neuroprotection by a caspase inhibitor in acute bacterial meningitis [J].
Braun, JS ;
Novak, R ;
Herzog, KH ;
Bodner, SM ;
Cleveland, JL ;
Tuomanen, EI .
NATURE MEDICINE, 1999, 5 (03) :298-302
[4]   MODULATION OF INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 ON HUMAN CORONARY SMOOTH-MUSCLE CELLS BY CYTOKINES [J].
BRAUN, M ;
PIETSCH, P ;
FELIX, SB ;
BAUMANN, G .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (12) :2571-2579
[5]   The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat [J].
Davies, CA ;
Loddick, SA ;
Toulmond, S ;
Stroemer, RP ;
Hunt, J ;
Rothwell, NJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (01) :87-98
[6]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[7]   Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme [J].
Dinarello, CA .
MOLECULAR MECHANISMS OF FEVER, 1998, 856 :1-11
[8]   Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation [J].
Fantuzzi, G ;
Sacco, S ;
Ghezzi, P ;
Dinarello, CA .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 273 (01) :R400-R406
[9]   Endothelin-1 in subarachnoid hemorrhage - An acute-phase reactant produced by cerebrospinal fluid leukocytes [J].
Fassbender, K ;
Hodapp, B ;
Rossol, S ;
Bertsch, T ;
Schmeck, J ;
Schütt, S ;
Fritzinger, M ;
Horn, P ;
Vajkoczy, P ;
Wendel-Wellner, M ;
Ragoschke, A ;
Kuehl, S ;
Brunner, J ;
Schürer, L ;
Schmiedeck, P ;
Hennerici, M .
STROKE, 2000, 31 (12) :2971-2975
[10]  
Furlan R, 1999, J IMMUNOL, V163, P2403